Stocktoria
ZIMMER BIOMET HOLDINGS, INC. ZBH
NYSE · XNYS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2001-07-25
ZIMMER BIOMET HOLDINGS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $8.2B | $7.7B | $7.4B | $6.9B | $6.8B |
| SG&A expense | $3.3B | $2.9B | $2.8B | $2.8B | $2.8B |
| Operating income | $1.1B | $1.3B | $1.3B | $696.3M | $860.3M |
| Income tax | $125.7M | $131.4M | $42.2M | $112.3M | $53.5M |
| Net income | $705.1M | $903.8M | $1.0B | $231.4M | $401.6M |
| EPS (diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
| Operating cash flow | $1.7B | $1.5B | $1.6B | $1.4B | $1.5B |
| Free cash flow | $1.5B | $1.3B | $1.3B | $1.2B | $1.4B |
| Cash & equivalents | $591.9M | $525.5M | $415.8M | $375.7M | $378.1M |
| Inventory | $2.3B | $2.2B | $2.4B | $2.1B | $2.1B |
| Total assets | $23.1B | $21.4B | $21.5B | $21.1B | $23.5B |
| Total liabilities | $10.4B | $8.9B | $9.0B | $9.0B | $10.8B |
| Shareholders' equity | $12.7B | $12.5B | $12.5B | $12.0B | $12.7B |
Source: SEC EDGAR filings · CIK 0001136869 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.